Basal ganglia pathophysiology in Parkinson's disease

Annals of Neurology

Volumn 65, Issue 5, 2009, Pages 618-

  Montgomery Jr , Erwin B ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DEOXYGLUCOSE; OXIDOPAMINE;

BASAL GANGLION; GLOBUS PALLIDUS; LETTER; MICROELECTRODE; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS;

ANIMALS; BASAL GANGLIA; DISEASE MODELS, ANIMAL; HUMANS; PARKINSON DISEASE;

EID: 67249116825     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21649     Document Type: Letter

References (6)

1. Obeso J, Marin C, Rodriguez-Oroz C, et al. The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Ann Neurol 2008;64:S30-S46.
2. Montgomery EB, Jr. Subthalamic nucleus neuronal activity in Parkinson's disease and epilepsy patients. Parkinsonism Relat Disord 2008;14:120-125.
3. Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:142-151.
4. Montgomery EB, Jr., Buchholz SR, Delitto A, Collins RC. Alterations in basal ganglia physiology following MPTP in monkeys. New York: Academic Press, 1986:679-682.
5. Montgomery EB Jr. Basal ganglia physiology and pathophysiology: a reappraisal. Parkinsonism Relat Disord 2007;13:455-465. (Pubitemid 350102311)
6. Montgomery EB Jr. Effects of GPi stimulation on human thalamic neuronal activity. Clin Neurophysiol 2006;117:2691-2702. (Pubitemid 44751627)